Journey Medical Corp
DERM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867066
No open-market purchases or sales by Journey Medical Corp insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $75.2M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Journey Medical Corp changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 36 | 33 | −3 |
| Shares | 1.36M | 1.82M | +458.0K (+33.7%) |
| Value | $7.80M | $6.68M | −$1.13M (−14.4%) |
New holders (9)
Institutions that held Journey Medical Corp at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tang Capital Management LLC | 138,625 | $510.1K | 0.05% |
| Heron Bay Capital Management | 33,669 | $123.9K | 0.03% |
| Envestnet Asset Management Inc | 28,975 | $106.6K | 0.00% |
| Goldman Sachs Group Inc | 19,965 | $73.5K | 0.00% |
| Prelude Capital Management, LLC | 15,060 | $55.4K | 0.00% |
| Royce & Associates LP | 12,654 | $46.6K | 0.00% |
| Nwam LLC | 11,820 | $40.7K | 0.00% |
| Tower Research Capital LLC (TRC) | 5,038 | $18.5K | 0.00% |
| IFP Advisors, Inc | 3,403 | $12.5K | 0.00% |
Sold out (12)
Institutions that held Journey Medical Corp at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| EAM Investors, LLC | 110,509 | $636.5K |
| Jane Street Group, LLC | 27,749 | $159.8K |
| Virtu Financial LLC | 26,586 | $153.0K |
| Cubist Systematic Strategies, LLC | 23,438 | $135.0K |
| Man Group plc | 18,268 | $105.2K |
| Independent Financial Group, LLC | 17,202 | $99.1K |
| UBS Group AG | 13,376 | $77.0K |
| Citadel Advisors LLC | 11,357 | $65.4K |
| Advisor Group Holdings, Inc. | 5,455 | $31.4K |
| Tucker Asset Management LLC | 2,600 | $15.0K |
| FMR LLC | 128 | $734 |
| RIA Advisory Group LLC | 1,767 | – |